Archive

Public Citizen's comments to FTC regarding AbbVie/Allergan merger
Public Citizen's comments to FTC regarding AbbVie/Allergan merger

The FTC should more fully consider the range of harms to consumers, and require stronger conditions to prevent anticompetitive conduct, June 11th 2020

press to zoom
Letter to GAO
Letter to GAO

An assessment of the prevalence of rebate traps in pharmaceutical markets and their effects on pharmaceutical pricing, competition, and innovation. June 10, 2020

press to zoom
Letter to GAO
Letter to GAO

Proposal asking the Government Accountability Office (GAO) to conduct an assessment of the prevalence of rebate traps in pharmaceutical markets and their effects on pharmaceutical pricing, competition, and innovation. June 10, 2020

press to zoom
Letter from 9 U.S senators opposing the AbbVie allergen merger and need to investigate rebate walls
Letter from 9 U.S senators opposing the AbbVie allergen merger and need to investigate rebate walls

September 17, 2019

press to zoom